Keynote
Hormone Therapy After Breast Cancer: What the Evidence Supports
Examining the evidence surrounding survivorship and hormone therapy.
Examine receptor biology, tumor phenotype, 17β-estradiol, P4 progesterone, synthetic progestins, route, dose, metabolic health, recurrence risk, and the evolving evidence surrounding survivorship.
Day 1
You Can Attend Another Conference…
Or You Can See the Patient Differently.
Three days connecting the literature, physiology, clinical application and objective measurement behind Optimal Health Medicine®.
November 6-8, 2026 • Fort Lauderdale, Florida
The OHM™ EVOLVE 2026 conference provides professional education for healthcare professionals and practice leaders. Content is not individualized medical, legal, or financial advice and does not replace independent professional judgment. No specific clinical or business outcome is guaranteed. OHM™ EVOLVE 2026 does not offer CME credits. Presented by Medical Practice Business Development, LLC. Contact info@ohmevolve.com for additional questions or concerns.
